根據 3 位華爾街分析師的預測，Gerresheimer AG 的收入預期範圍從 $540.75M 到 $502.64M
Gerresheimer AG 的盈利品質評分是多少？
Gerresheimer AG 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Gerresheimer AG 何時發布財報？
Gerresheimer AG 的下一份財報預計在 2026-05-27 發布
Gerresheimer AG 的預期收益是多少？
根據華爾街分析師的預測，Gerresheimer AG 的預期收益為 $616.03M
Gerresheimer AG 是否超出收益預期？
Gerresheimer AG 最近的收益為 $， 預期。
關鍵數據
前收市價
$6.3
開盤價
$5.9
當日範圍
$5.9 - $5.9
52週區間
$4.71 - $20.3
交易量
--
平均成交量
342
股息收益率
--
每股盈餘 (TTM)
0.20
市值
$815.1M
什麼是 Gerresheimer AG？
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,535 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
